Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

NowPatient vs tru Weight Loss

NowPatient
Graded #222

Higher grade

vs+6.600000000000001
tru Weight Loss
Graded #354

Lower grade

The verdict

NowPatient takes it — 65.5/100 to 58.9/100.

NowPatient grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. NowPatient is a US-UK telehealth platform offering brand-name GLP-1 weight management access including Mounjaro, Wegovy (injection and oral tablet), and Saxenda.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valuetru Weight Loss +3
35
38
Dose & formulationNowPatient +21
93
72
Clinical oversightNowPatient +10
86
76
Labs & monitoringtru Weight Loss +18
54
72
FulfillmentNowPatient +8
70
62
Contract termsNowPatient +35
55
20
NowPatient · left bartru Weight Loss · right bar

The numbers

MetricNowPatienttru Weight Loss
WeighScore65.5/10058.9/100
GradeCC
Scorecard rank#222#354
Semaglutide$1,349/mo (brand Wegovy)$299/mo (all doses, 3-month plan, compounded)
Tirzepatide$1,069/mo (brand Mounjaro, promotional rate)$399/mo (all doses, 3-month plan, compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessYesCompounded only
Oral / sublingualYesInjection only
NowPatient

Graded #222 · C

Strengths

  • Free telehealth consultation — you only pay for the medication
  • Brand-name Mounjaro, Wegovy injection, Wegovy oral tablet, and Saxenda all available
  • One of the few platforms offering Wegovy in both injection and oral pill form
  • No compounded options — every drug is FDA-approved brand-name

Where it loses points

  • Cash-pay pricing tracks full brand list price (~$1,000–$1,350/mo)
  • No compounded semaglutide or tirzepatide (usually the cheaper route)
  • State availability determined during intake, not shown upfront
  • Does not offer Foundayo (orforglipron)
tru Weight Loss

Graded #354 · C

Strengths

  • Flat, transparent pricing (299/mo semaglutide, 399/mo tirzepatide)
  • All-inclusive: consult, lab work, medication delivery, nutritionist and behavioral coaching
  • Directed by a named physician (Neha Grover, MD) from a physical clinic

Where it loses points

  • Requires a 3-month commitment before you can cancel
  • States served are not specified and the dispensing pharmacy is not named
  • Does not accept insurance, HSA, or FSA

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard